Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Angola has been showing significant growth in recent years.
Customer preferences: Angola has a population of over 30 million people, and the demand for vaccines has been increasing due to the rising awareness about the importance of immunization. The government has been making efforts to provide free vaccines to the population, especially for children under five years old. However, there is also a growing demand for other vaccines, such as those for yellow fever, meningitis, and hepatitis, among others.
Trends in the market: One of the main trends in the Other Vaccines market in Angola is the increasing availability of vaccines. Pharmaceutical companies are expanding their operations in the country, and there is also a growing number of private clinics and hospitals that offer vaccination services. This has led to increased competition in the market, which has resulted in lower prices for consumers.Another trend in the market is the growing demand for travel vaccines. Angola is a popular destination for tourists, and many countries require travelers to be vaccinated against certain diseases before entering. This has led to an increase in demand for vaccines such as yellow fever, which is mandatory for travelers to Angola.
Local special circumstances: One of the major challenges in the Other Vaccines market in Angola is the lack of infrastructure and resources. The country has a poor healthcare system, and many people live in rural areas with limited access to medical facilities. This has made it difficult for the government to provide vaccines to the entire population, and has also made it challenging for pharmaceutical companies to distribute their products.
Underlying macroeconomic factors: Angola is a developing country with a growing economy, and this has led to an increase in disposable income for many people. This has resulted in a higher demand for healthcare services, including vaccines. Additionally, the government has been investing in the healthcare sector, which has helped to improve the overall quality of healthcare in the country. However, there are still challenges that need to be addressed, such as improving infrastructure and increasing access to medical facilities in rural areas.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
